封面
市場調查報告書
商品編碼
1467626

2024-2032 年按產品類型、技術、疾病、最終用戶和地區分類的組織診斷市場報告

Tissue Diagnostics Market Report by Product Type, Technology, Disease, End-User, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2023 年,全球IMARC Group診斷市場規模達到 55 億美元。

組織診斷包括透過捕獲疾病的生物學背景來分析和測試特定組織樣本。它們用於檢測某些醫療狀況,如癌症和發炎性疾病,並揭示惡性腫瘤的確切類型和程度,這有助於確定潛在的原因和治療方案。組織診斷非常準確、廉價,並且可以透過核心活體組織切片和開放活體組織切片等不同技術進行。如今,免疫組織化學(IHC)、原位雜合技術(ISH)、數位病理學和特殊染色等先進技術也被用於進行這些診斷。

由於生育率下降和預期壽命延長,目前全球老年人口的整體比例正在穩步成長。這是促進市場成長的關鍵因素,因為老年人更容易患慢性病,因此需要經常檢查和診斷。除此之外,飲食模式的改變、飲酒量的增加以及個體體力活動的減少導致了多種生活方式疾病的發生率上升。除此之外,各年齡層各種癌症盛行率的上升也導致這些診斷服務的需求激增。

本報告回答的關鍵問題

  • 全球組織診斷市場有多大?
  • 2024-2032年全球組織診斷市場的預期成長率是多少?
  • 推動全球組織診斷市場的關鍵因素是什麼?
  • COVID-19 對全球組織診斷市場有何影響?
  • 根據產品類型,全球組織診斷市場的細分如何?
  • 基於該技術的全球組織診斷市場的詳細情形如何?
  • 基於該疾病的全球組織診斷市場的細分是什麼?
  • 基於最終用戶的全球組織診斷市場的詳細情形如何?
  • 全球組織診斷市場的關鍵區域有哪些?
  • 誰是全球組織診斷市場的主要參與者/公司?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球組織診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔:依產品類型
  • 市場區隔:按技術
  • 市場區隔:依疾病分類
  • 市場區隔:按最終用戶
  • 市場區隔:按地區
  • 市場預測

第 6 章:市場區隔:依產品類型

  • 儀器
    • 市場走向
    • 市場預測
  • 耗材
    • 市場走向
    • 市場預測

第 7 章:市場區隔:依技術

  • 免疫組織化學
    • 市場走向
    • 市場預測
  • 原位雜合技術
    • 市場走向
    • 市場預測
  • 數位病理學和工作流程管理
    • 市場走向
    • 市場預測
  • 特殊染色
    • 市場走向
    • 市場預測

第 8 章:市場區隔:依疾病分類

  • 乳癌
    • 市場走向
    • 市場預測
  • 胃癌
    • 市場走向
    • 市場預測
  • 淋巴瘤
    • 市場走向
    • 市場預測
  • 攝護腺癌
    • 市場走向
    • 市場預測
  • 非小細胞肺癌
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章:市場區隔:按最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 研究實驗室
    • 市場走向
    • 市場預測
  • 製藥公司
    • 市場走向
    • 市場預測
  • 合約研究組織
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章:市場區隔:按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 11 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章:價值鏈分析

第 13 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章:價格分析

  • 價格指標
  • 價格結構
  • 利潤分析

第15章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Roche
    • Danaher
    • Thermo Fisher Scientific
    • Abbott
    • Agilent Technologies
    • Merck
    • Sakura Finetek Japan
    • Abcam
    • BD
    • Qiagen
    • Bio SB
    • Biogenex
    • Cell Signaling Technology
Product Code: SR112024A1349

The global tissue diagnostics market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, technology, disease and end-user.

Breakup by Product Type:

Instruments

Consumables

Breakup by Technology:

Immunohistochemistry

In Situ Hybridization

Digital Pathology and Workflow Management

Special Staining

Breakup by Disease:

Breast Cancer

Gastric Cancer

Lymphoma

Prostate Cancer

Non-Small Cell Lung Cancer

Others

Breakup by End-User:

Hospitals

Research Laboratories

Pharmaceutical Companies

Contract Research Organizations

Others

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Key Questions Answered in This Report

  • 1. How big is the global tissue diagnostics market?
  • 2. What is the expected growth rate of the global tissue diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global tissue diagnostics market?
  • 4. What has been the impact of COVID-19 on the global tissue diagnostics market?
  • 5. What is the breakup of the global tissue diagnostics market based on the product type?
  • 6. What is the breakup of the global tissue diagnostics market based on the technology?
  • 7. What is the breakup of the global tissue diagnostics market based on the disease?
  • 8. What is the breakup of the global tissue diagnostics market based on the end-user?
  • 9. What are the key regions in the global tissue diagnostics market?
  • 10. Who are the key players/companies in the global tissue diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunohistochemistry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 In Situ Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Digital Pathology and Workflow Management
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Special Staining
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Breast Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastric Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lymphoma
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Non-Small Cell Lung Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Contract Research Organizations
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Roche
    • 15.3.2 Danaher
    • 15.3.3 Thermo Fisher Scientific
    • 15.3.4 Abbott
    • 15.3.5 Agilent Technologies
    • 15.3.6 Merck
    • 15.3.7 Sakura Finetek Japan
    • 15.3.8 Abcam
    • 15.3.9 BD
    • 15.3.10 Qiagen
    • 15.3.11 Bio SB
    • 15.3.12 Biogenex
    • 15.3.13 Cell Signaling Technology

List of Figures

  • Figure 1: Global: Tissue Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Tissue Diagnostics Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Tissue Diagnostics Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Tissue Diagnostics Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Tissue Diagnostics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Tissue Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Tissue Diagnostics Industry: SWOT Analysis
  • Figure 9: Global: Tissue Diagnostics Industry: Value Chain Analysis
  • Figure 10: Global: Tissue Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Tissue Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 12: Global: Tissue Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Tissue Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Tissue Diagnostics (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Tissue Diagnostics (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Tissue Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Tissue Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Tissue Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Tissue Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Tissue Diagnostics (Special Staining) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Tissue Diagnostics (Special Staining) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Tissue Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Tissue Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Tissue Diagnostics (Gastric Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Tissue Diagnostics (Gastric Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Tissue Diagnostics (Lymphoma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Tissue Diagnostics (Lymphoma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Tissue Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Tissue Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Tissue Diagnostics (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Tissue Diagnostics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Tissue Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Tissue Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Tissue Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Tissue Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Tissue Diagnostics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Tissue Diagnostics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Tissue Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Tissue Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Tissue Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Tissue Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: North America: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: North America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia Pacific: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia Pacific: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Middle East and Africa: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Middle East and Africa: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Latin America: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Latin America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Tissue Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Tissue Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Tissue Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Tissue Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 5: Global: Tissue Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Tissue Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Tissue Diagnostics Market Structure
  • Table 8: Global: Tissue Diagnostics Market: Key Players